ENC1, SLAMF7 GREB1, EPHA7, CDH6, PKHD1, FBG, FLT3, ADAR2, and ANKRD1 are prominent in this category, suggesting their potential as therapeutic targets in various cancers [44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62]. This evidence concerns the gene GREB1 and cancer.